Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency

DRUG: Transdermal estradiol gel 0.1% 1.5mg/ day
DRUG: Transdermal estradiol gel 0.1% 2.0mg/ day

PHASE1,PHASE2

Phase

UNKNOWN

Status

Enrollment

OTHER_GOV

Sponsor class

Conditions

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare